Report of Foreign Issuer (6-k)
March 14 2018 - 10:52AM
Edgar (US Regulatory)
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Month of March, 2018
Commission File Number: 001-35892
GW PHARMACEUTICALS PLC
(Translation of registrant’s name
into English)
Sovereign House
Vision Park
Histon
Cambridge CB24 9BZ
United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Results of Annual General Meeting
On March 14, 2018, GW Pharmaceuticals plc
(the “Company”) announced the results of the resolutions proposed at the Company’s Annual General Meeting. The
announcement is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Other Events
On March 14, 2018, the Company also updated
its corporate presentation. A copy of the updated corporate presentation is attached hereto as Exhibit 99.2 and is incorporated
by reference herein.
The information contained in Exhibit 99.1
and Exhibit 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended,
or the Exchange Act, unless expressly set forth by specific reference in such a filing.
Exhibits
|
99.1
|
Announcement of Results
of Annual General Meeting
|
|
99.2
|
Updated Corporate Presentation
dated March 14, 2018
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
GW Pharmaceuticals plc
|
|
|
|
|
By:
|
/s/ Adam George
|
|
Name:
|
Adam George
|
|
Title:
|
Company Secretary
|
|
|
|
Date: March 14, 2018
|
|
|